samedan logo
home > ebr

European Biopharmaceutical Review


European Biopharmaceutical Review (EBR) is a journal designed to fill a unique position in scientific publishing. Published quarterly, it provides a dedicated platform of communication and information for the European biopharmaceutical market across Europe, North America, and the rest of the world.

With editorial consisting of in-depth articles, case studies, meetings, and report reviews written by specialists with hands-on experience in the biopharma industry; traditional multi-national pharma companies; investment houses; and industry-associated governmental, economic, and societal bodies. Each quarterly edition examines topical areas of importance across the board of biopharmaceutical research and development, with regular feature sections on BioBusiness Development, Research and Innovation, BioDiscovery, BioManufacturing plus special focuses on geographic or therapeutic territories.

For further information please contact:


Helga Schweissguth


Victoria Parker



Connect with us on Twitter: follow @EBRmagazine

Click here to view the digital version of EBR




Featured in this issue

Cell Culture
Defining Cell Culture Conditions to Drive Cell Identity and Scalability in Cell Therapy

Dr Aida Moreno-Moral and Dr David Anderson at Mogrify

Using epigenetically predicted factors to mimic in vivo microenvironments and systematically define in vitro culture conditions for optimal cell maintenance and differentiation
  CAR T Cell Therapy
Droplet Digital PCR for Safe and Effective CAR T Cell Therapies

Mark White at Bio-Rad

ddPCR can quantify transgene copy numbers more precisely than standard qPCR and reduce risk for patients, but how else can it support CAR T cell production?


Published quarterly in
January, April,
July, and October


Industry Events

Bio Integrates 2021


Following the continued success of last year’s inaugural digital event, Life Science Integrates is delighted to announce the 3rd Bio Integrates conference. Addressing the needs of innovative companies developing the therapies of tomorrow, this one-day conference provides a unique forum to discuss the major challenges impacting the sector.
More info >>

News and Press Releases

World-class multidisciplinary partnership to take science one step closer to building fully functional organs at lightning speed

In the European project ENLIGHT, researchers from academic centers and leading industries across Europe are joining forces to develop a living model of the pancreas to enable better testing of diabetes medication.
More info >>

White Papers

Protein Therapeutics

Reading Scientific Services Ltd (RSSL)

More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement